... and operating income are each forecast to increase as core products including Allelock continue to grow, and new product Patanol contributes to growth. ...
The medication prescribed was a topical antihistamine and most likely Patanol. Since it is topical, it will have limited systemic effects, ...
He rates the stock at "Accumulate," or "Buy." Buck expects better sales of Patanol ophthalmic solutions, which were launched in Japan in September. ...